Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christine Lu, Ph.D.

Co-Author

This page shows the publications co-authored by Christine Lu and Dennis Ross-Degnan.
Connection Strength

4.047
  1. Impact of High-Deductible Health Plans on Medication Use Among Individuals With Bipolar Disorder. Psychiatr Serv. 2021 08 01; 72(8):926-934.
    View in: PubMed
    Score: 0.241
  2. Out-of-Pocket Spending Inequity Among High-Deductible Health Plan Members with Bipolar Disorder. J Gen Intern Med. 2021 Apr 12.
    View in: PubMed
    Score: 0.240
  3. Experiences of health care costs among people with employer-sponsored insurance and bipolar disorder. J Affect Disord. 2021 02 15; 281:41-50.
    View in: PubMed
    Score: 0.232
  4. Effect of high-deductible insurance on health care use in bipolar disorder. Am J Manag Care. 2020 06; 26(6):248-255.
    View in: PubMed
    Score: 0.226
  5. Cost burden of hepatitis C virus treatment in commercially insured patients. Am J Manag Care. 2019 12 01; 25(12):e379-e387.
    View in: PubMed
    Score: 0.218
  6. Vulnerable And Less Vulnerable Women In High-Deductible Health Plans Experienced Delayed Breast Cancer Care. Health Aff (Millwood). 2019 03; 38(3):408-415.
    View in: PubMed
    Score: 0.207
  7. Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer. Breast Cancer Res Treat. 2018 Aug; 171(1):235-242.
    View in: PubMed
    Score: 0.196
  8. Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment. J Clin Oncol. 2018 04 10; 36(11):1121-1127.
    View in: PubMed
    Score: 0.193
  9. Effect of High-Deductible Insurance on High-Acuity Outcomes in Diabetes: A Natural Experiment for Translation in Diabetes (NEXT-D) Study. Diabetes Care. 2018 05; 41(5):940-948.
    View in: PubMed
    Score: 0.192
  10. Diabetes Outpatient Care and Acute Complications Before and After High-Deductible Insurance Enrollment: A Natural Experiment for Translation in Diabetes (NEXT-D) Study. JAMA Intern Med. 2017 03 01; 177(3):358-368.
    View in: PubMed
    Score: 0.180
  11. Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan. Pharmacoepidemiol Drug Saf. 2015 Oct; 24(10):1026-35.
    View in: PubMed
    Score: 0.162
  12. How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid? Clin Ther. 2015 Jul 01; 37(7):1420-1432.e1.
    View in: PubMed
    Score: 0.159
  13. Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmacies. J Pharm Policy Pract. 2015; 8(1):15.
    View in: PubMed
    Score: 0.158
  14. Patient access schemes in Asia-pacific markets: current experience and future potential. J Pharm Policy Pract. 2015; 8(1):6.
    View in: PubMed
    Score: 0.156
  15. Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand. J Pharm Policy Pract. 2015; 8(1):7.
    View in: PubMed
    Score: 0.156
  16. Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: an interrupted time series study. Health Policy. 2014 Jun; 116(2-3):196-205.
    View in: PubMed
    Score: 0.144
  17. Association between prior authorization for medications and health service use by Medicaid patients with bipolar disorder. Psychiatr Serv. 2011 Feb; 62(2):186-93.
    View in: PubMed
    Score: 0.118
  18. Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study. Clin Ther. 2011 Jan; 33(1):135-44.
    View in: PubMed
    Score: 0.118
  19. Unintended impacts of a Medicaid prior authorization policy on access to medications for bipolar illness. Med Care. 2010 Jan; 48(1):4-9.
    View in: PubMed
    Score: 0.110
  20. Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007. BMC Health Serv Res. 2008 Apr 07; 8:75.
    View in: PubMed
    Score: 0.097
  21. Diabetes Microvascular Disease Diagnosis and Treatment After High-Deductible Health Plan Enrollment. Diabetes Care. 2021 Sep 29.
    View in: PubMed
    Score: 0.062
  22. Integrating Stakeholder Engagement With Claims-Based Research on Health Insurance Design and Bipolar Disorder. Psychiatr Serv. 2021 02 01; 72(2):186-194.
    View in: PubMed
    Score: 0.058
  23. Association Between Switching to a High-Deductible Health Plan and Major Cardiovascular Outcomes. JAMA Netw Open. 2020 07 01; 3(7):e208939.
    View in: PubMed
    Score: 0.057
  24. High-Deductible Insurance and Delay in Care for the Macrovascular Complications of Diabetes. Ann Intern Med. 2018 12 18; 169(12):845-854.
    View in: PubMed
    Score: 0.051
  25. Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans. Breast Cancer Res Treat. 2018 Sep; 171(2):449-459.
    View in: PubMed
    Score: 0.049
  26. Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer. Value Health. 2017 12; 20(10):1345-1354.
    View in: PubMed
    Score: 0.046
  27. Erratum to: Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer. Breast Cancer Res Treat. 2016 11; 160(2):385.
    View in: PubMed
    Score: 0.044
  28. Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer. Breast Cancer Res Treat. 2016 07; 158(2):333-40.
    View in: PubMed
    Score: 0.043
  29. Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis. BMJ Open. 2016 Mar 17; 6(3):e008671.
    View in: PubMed
    Score: 0.042
  30. Policies and programs to facilitate access to targeted cancer therapies in Thailand. PLoS One. 2015; 10(3):e0119945.
    View in: PubMed
    Score: 0.039
  31. Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study. Clin Ther. 2010 Apr; 32(4):729-41; discussion 716.
    View in: PubMed
    Score: 0.028
  32. Prior authorization for antidepressants in Medicaid: effects among disabled dual enrollees. Arch Intern Med. 2009 Apr 27; 169(8):750-6.
    View in: PubMed
    Score: 0.026
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.